About Natalie Mount
Natalie Mount is a director at Allotera Therapeutics.
Experience
This experience comes from Natalie Mount's profile and from SEC filings. For roles taken from filings, the years are when the filings name Natalie Mount in the role, so the role may have started earlier or lasted longer.
CL
Cytospire Therapeutics Ltd Current
Chief Executive Officer
2023 – Present
AB
Abingworth Current
Venture Partner
2022 – Present
WU
Wugen Current
Board Member
2022 – Present
Allotera Therapeutics, Inc.
Director
2025 – 2026 · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
RT
Rinri Therapeutics
Independent Board Director
2020 – 2023
AB
Adaptate Biotherapeutics
Chief Executive Officer
2019 – 2022
GB
GenSight Biologics
Independent Board Director
2017 – 2021
GT
GammaDelta Therapeutics
Chief Scientific Officer
2017 – 2019
CC
Cell and Gene Therapy Catapult
Chief Clinical Officer
2012 – 2017
NL
New Therapeutics Consulting Ltd
Owner
2012
PN
Pfizer Neusentis
Acting Head of Clinical Research (2011 – 2012)
Executive Director, Regenerative Medicine Clinical Development Lead (2009 – 2011)
2009 – 2012
Key Colleagues at Startups
The people Natalie Mount works with at each company, as listed on that company's latest Form D.
Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
Drew Dennison
Director
KL
Kevin Li
Director
ND
Niall O'Donnell
Director
Kumar Srinivasan
President & Chief Executive Officer, director
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
PK
Peter Kiener
Chair
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
Bali Muralidhar
Director